Clopidogrel vs Durvalumab

Clopidogrel vs Durvalumab: Overview

This comparison examines the pharmacological differences between Clopidogrel and Durvalumab.

Mechanism of Action

Clopidogrel: Irreversibly blocks P2Y12 ADP receptor on platelets.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Clopidogrel — 6 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Clopidogrel — C16H16ClNO2S.

Molecular Weight: Clopidogrel — 321.8220 g/mol.

Type: Clopidogrel — Small molecule; Durvalumab — Antibody.